Egbert Vincent Madamba

Title(s)CLIN RSCH SUPV 2, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical utility of a 30% reduction in VCTE-derived liver stiffness measurement for identifying histologic improvement in MASH. Hepatology. 2026 Sep 02. Loomba R, Chen R, Wang Y, Bettencourt R, Madamba E, Tesfai K, Richards L, Muthiah M, Tan E, Young DY, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 42691332.
      View in: PubMed   Mentions:
    2. Prevalence and Risk Factors Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Fibrosis Among Overweight Individuals: Implications for Screening Guidelines. Am J Gastroenterol. 2026 Jun 24. Mironova M, Tesfai K, Madamba E, Richards L, Bettencourt R, Docherty M, Loomba R. PMID: 42333597.
      View in: PubMed   Mentions:    Fields:    
    3. Longitudinal Validation of Clinical Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease in a Prospective Cohort of Individuals With Type 2 Diabetes. Gastro Hep Adv. 2026; 5(9):101022. Dounel J, Díaz LA, Bettencourt R, Tavaglione F, Madamba E, Richards L, Loomba R, Ajmera V. PMID: 42405291; PMCID: PMC13332004.
      View in: PubMed   Mentions:
    4. The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use. Gastroenterology. 2026 May; 170(5):1033-1046. Tavaglione F, Vaz J, Jamialahmadi O, Díaz LA, Ajmera V, Contrano D, Madamba E, Singh S, Bettencourt R, Richards L, Hagström H, Loomba R. PMID: 41739005.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Clinical Utility of a 50% and 30% Decline in Magnetic Resonance Imaging-Proton Density Fat Fraction in Predicting Fibrosis Improvement in Metabolic Dysfunction-associated Steatohepatitis. Clin Gastroenterol Hepatol. 2026 Feb 06. Loomba R, Daniel PCN, Wang Y, Bettencourt R, Madamba E, Siddiqi H, Richards L, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 41655805.
      View in: PubMed   Mentions:    Fields:    
    6. Clinical Trial: Semaglutide Versus Placebo in NIT-Assessed MASH-A Multicenter Randomised Placebo-Controlled Trial (SAMARA). Aliment Pharmacol Ther. 2026 Apr; 63(8):1080-1088. Ajmera V, Vuppalanchi R, Khalili M, Sheikh MY, Risser J, Klein S, Tincopa M, Madamba E, Singh S, Siddiqi H, Cortez-Moreno D, Contrano D, Hofflich H, Abeles R, Lunde O, Grunvald E, Bettencourt R, He F, Jain S, Richards L, Loomba R. PMID: 41527269.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    7. Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracing. JHEP Rep. 2026 Mar; 8(3):101733. Tavaglione F, Ajmera V, Díaz LA, Li K, Madamba E, Bettencourt R, Richards L, Hellerstein M, Loomba R. PMID: 41716746; PMCID: PMC12914784.
      View in: PubMed   Mentions:
    8. Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Aliment Pharmacol Ther. 2026 Mar; 63(6):838-849. Tesfai K, Díaz LA, Arab JP, Arrese M, Idalsoaga F, Ayares G, Agrawal S, Barreyro FJ, Gadano A, Marciano S, Morales JM, Villela-Nogueira C, Leite N, Salles G, Cardoso CR, Couto CA, Theodoro R, de Sousa Dias Monteiro MJ, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Huang DQ, Madamba E, Singh S, Lokanadham S, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 41147688; PMCID: PMC12671836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification. J Hepatol. 2025 Nov; 83(5):1023-1034. Tavaglione F, Díaz LA, Ajmera V, Madamba E, Singh S, Bettencourt R, Richards L, Loomba R. PMID: 40517819.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    10. Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD). Hepatol Commun. 2025 06 01; 9(6). Díaz LA, Tavaglione F, Mittal N, Bettencourt R, Amangurbanova M, Johnson A, Marti-Aguado D, Tincopa M, Loomba R, Khan-Riches A, Madamba E, Siddiqi H, Richards L, Sirlin CB, Ajmera V, Loomba R. PMID: 40377491; PMCID: PMC12088636.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    11. Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy. Hepatology. 2026 Apr 01; 83(4):907-914. Loomba R, Daniel PCN, Amangurbanova M, Bettencourt R, Madamba E, Siddiqi H, Richards L, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 40359098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. High inherited risk predicts age-associated increases in fibrosis in patients with MASLD. J Hepatol. 2025 Oct; 83(4):849-859. Díaz LA, Alazawi W, Agrawal S, Arab JP, Arrese M, Idalsoaga F, Barreyro FJ, Gadano A, Marciano S, Martínez Morales J, Villela-Nogueira C, Leite N, Couto CA, Theodoro R, Monteiro MJSD, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Madamba E, Bettencourt R, Richards LM, Majithia AR, Khera AV, Loomba R, Ajmera V. PMID: 40334848; PMCID: PMC12453583.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    13. A Prospective Study on the Prevalence of MASLD in Patients With Type 2 Diabetes and Hyperferritinaemia. Aliment Pharmacol Ther. 2025 Feb; 61(3):456-464. Amangurbanova M, Huang DQ, Noureddin N, Tesfai K, Bettencourt R, Siddiqi H, Lopez SJ, Cervantes V, Madamba E, Loomba R. PMID: 39499168.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    14. MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH. Gut. 2024 07 11; 73(8):1343-1349. Loomba R, Amangurbanova M, Bettencourt R, Madamba E, Siddiqi H, Richards L, Behling C, Sirlin CB, Gottwald MD, Feng S, Margalit M, Huang DQ. PMID: 38418210; PMCID: PMC12355936.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    15. Repeatability of vibration-controlled transient elastography versus magnetic resonance elastography in patients with cirrhosis: A prospective study. Aliment Pharmacol Ther. 2024 08; 60(4):484-491. Siddiqi H, Huang DQ, Mittal N, Nourredin N, Bettencourt R, Madamba E, Amangurbanova M, Hernandez C, Sirlin C, Yin M, Loomba R. PMID: 38863232; PMCID: PMC11618574.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Aliment Pharmacol Ther. 2024 08; 60(3):369-377. Bridi L, Agrawal S, Tesfai K, Madamba E, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 38825972; PMCID: PMC11236495.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    17. Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV. Clin Gastroenterol Hepatol. 2024 Jul; 22(7):1427-1435.e6. Kardashian A, Lloyd A, Vilar-Gomez E, Naggie S, Sulkowski MS, Woreta T, Lake JE, Crandall H, Loomba R, Wilson LA, Sterling RK, Heath S, Gawrieh S, Chalasani NP, Price JC, HIV NASH Clinical Research Network. PMID: 38582290; PMCID: PMC11193609.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes. Hepatology. 2024 05 01; 79(5):1098-1106. Ajmera V, Tesfai K, Sandoval E, Lopez S, Cervantes V, Madamba E, Bettencourt R, Manousou P, Richards L, Loomba R. PMID: 37862551; PMCID: PMC11023802.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    19. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Ther Adv Gastroenterol. 2021; 14:17562848211050436. Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, Behling C, Valasek MA, Loomba R. PMID: 34646360; PMCID: PMC8504217.
      View in: PubMed   Mentions: 17  
    20. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021 05; 53(9):1030-1037. Park JG, Jung J, Verma KK, Kang MK, Madamba E, Lopez S, Qas Yonan A, Liu A, Bettencourt R, Sirlin C, Loomba R. PMID: 33764550; PMCID: PMC8514119.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    21. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut. 2021 10; 70(10):1946-1953. Jung J, Loomba RR, Imajo K, Madamba E, Gandhi S, Bettencourt R, Singh S, Hernandez C, Valasek MA, Behling C, Richards L, Fowler K, Sirlin CB, Nakajima A, Loomba R. PMID: 33214165; PMCID: PMC8131405.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    Egbert Vincent's Networks
    Concepts (61)
    Derived automatically from this person's publications.
    _
    Co-Authors (21)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _